Introduction
Receiving a diagnosis of advanced breast cancer or non-small cell lung cancer can be overwhelming. For many patients, treatment decisions become increasingly complex after standard therapies stop working or cancer progresses despite prior treatment. Advances in targeted cancer therapies have created new options for some patients, offering innovative approaches designed to attack cancer cells more precisely.
Datroway is a targeted cancer treatment known as an antibody-drug conjugate. It combines a monoclonal antibody that recognizes Trop-2, a protein commonly expressed on certain cancer cells, with a chemotherapy payload that is delivered directly to those cells. This targeted approach is designed to help deliver treatment where it is needed while minimizing exposure to healthy tissues.
Because Datroway is a specialty oncology medication administered through infusion, treatment costs can be substantial. Many patients researching the Datroway patient assistance program need prescription management and treatment expenses while maintaining access to care. Prescription Hope helps patients access their medication’s patient assistance program.
What Is the Datroway Patient Assistance Program?
Understanding Datroway Prescription Assistance
Pharmaceutical manufacturers launch patient assistance programs to help qualified patients access their brand-name medications at affordable rates.
Programs such as the Datroway Patient Assistance Program help patients pay for medications by offering brand-name medications at low, affordable costs.
However, these programs often have a downside. Patients report difficulties navigating the application process, leaving them feeling overwhelmed and frustrated.
How Expert Advocates Help Make Datroway More Affordable
Professional Application Management
Prescription Hope provides medication advocate support for patients wishing to apply for patient assistance programs. Our patient advocates work hard on your behalf, taking care of the application process from start to finish.
We complete all your forms, collect necessary documentation, secure signatures from healthcare providers, and coordinate with the manufacturer throughout the process.
Ongoing Patient Support
Our patient-centered support provides long-term medication assistance. For as long as you are a patient with us, we will continue to handle the necessary administrative tasks required by the patient assistance program. Our service includes refill scheduling, yearly renewals, document updates, program monitoring, and more.
Datroway Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
Prescription Hope’s service rate is a simple $70.00 per month, per medication. Our expert patient advocates work on your behalf in navigating your intended patient assistance program, from start to finish.
Datroway Patient Assistance Eligibility
General Eligibility Requirements
Datroway eligibility depends on patient assistance qualifications. Every patient assistance program requires certain standards to qualify. While each program differs in specific criteria, most use several general categories to determine eligibility. Some of those include:
Insurance: Each program maintains its own insurance coverage status requirements.
Residency: All programs require valid US residency to qualify.
Income: Every program has its own income threshold criteria.
Prescription: All programs require a valid prescription to qualify.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Ready to enroll in Datroway assistance? Completing the Datroway application process is as simple as following Prescription Hope’s 6 enrollment steps:
- Submit Information: Fill out our online enrollment form.
- Advocate Contact: A patient advocate will reach out within 1-2 business days.
- Document Collection: Our team then collects all documents.
- Provider Coordination: Your team of patient advocates will also work with providers to secure needed signatures.
- Program Submission: Once everything is collected, we submit your application and continue to coordinate with the manufacturer throughout the processing stage.
- Medication Delivery: After approval, patients often receive their medication within 2 weeks. All medications ship directly from the manufacturer to your door or doctor’s office.
Understanding Datroway
How Datroway Works
Datroway is an antibody-drug conjugate (ADC), a type of targeted cancer therapy that combines a monoclonal antibody with a chemotherapy payload. The medication is designed to identify and attach to Trop-2, a protein commonly found on the surface of certain cancer cells.
Once Datroway binds to a Trop-2-expressing cancer cell, the cell absorbs the medication. Inside the cell, the chemotherapy component is released. This payload is a topoisomerase I inhibitor that damages cancer cell DNA, leading to cell death.
This targeted delivery system is designed to bring chemotherapy directly to cancer cells through antibody-mediated targeting. By combining the precision of targeted therapy with the cancer-killing effects of chemotherapy, Datroway offers a unique treatment approach for eligible patients with advanced cancers.
What Conditions Does Datroway Treat?
Datroway is FDA-approved for the treatment of adults with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have previously received endocrine-based therapy and chemotherapy for advanced disease.
The medication is also approved for adults with locally advanced or metastatic EGFR-mutated non-small cell lung cancer whose disease has progressed after treatment with EGFR-directed therapy and platinum-based chemotherapy.
Healthcare providers may consider Datroway when cancer has spread, cannot be surgically removed, or continues to progress despite prior treatment. The medication provides an additional targeted treatment option for patients who meet specific FDA-approved treatment criteria based on their cancer type and treatment history.
Benefits of Treatment
Datroway offers a targeted approach to cancer treatment by combining antibody therapy with direct chemotherapy delivery. This mechanism allows the medication to selectively target Trop-2-expressing cancer cells while delivering a potent anti-cancer payload.
Potential benefits include providing an additional treatment option for patients with advanced breast cancer or non-small cell lung cancer after previous therapies have stopped working. Clinical studies demonstrated tumor responses in some patients receiving treatment, supporting its role as an option for eligible individuals with advanced disease.
The medication’s targeted design distinguishes it from traditional chemotherapy by focusing treatment on cancer cells through antibody recognition. Healthcare providers evaluate treatment effectiveness through imaging studies, laboratory testing, symptom assessment, and ongoing clinical monitoring throughout therapy.
Because every patient’s cancer journey is different, treatment outcomes vary, and healthcare teams regularly assess response and tolerability to help guide ongoing care.
Important Safety Information and Side Effects
Datroway does not currently carry an FDA Boxed Warning. However, it has several important safety considerations that require close monitoring throughout treatment.
Common side effects include mouth sores, nausea, fatigue, hair loss, constipation, decreased appetite, vomiting, diarrhea, anemia, low white blood cell counts, dry eyes, and eye irritation. Because the medication affects rapidly dividing cells, blood count abnormalities and gastrointestinal side effects may occur.
One of the most serious risks associated with Datroway is interstitial lung disease (ILD) and pneumonitis. These conditions can be severe, life-threatening, or fatal. Patients should immediately report symptoms such as new or worsening cough, shortness of breath, fever, or difficulty breathing. Depending on severity, treatment may need to be interrupted, adjusted, or permanently discontinued.
Datroway can also cause ocular toxicity, including dry eye, keratitis, blurred vision, and eye irritation. Some patients may require ophthalmologic evaluations before and during treatment. Prompt reporting of new or worsening eye symptoms is important.
Painful mouth sores and oral inflammation are common and may require preventive care, supportive treatment, dose modifications, or temporary treatment interruptions. Bone marrow suppression may also occur, leading to neutropenia, anemia, and other blood count abnormalities that increase the risk of infection and other complications.
Infusion-related reactions may occur during or shortly after treatment and can include fever, chills, flushing, or breathing difficulties. Patients are monitored closely during administration to help manage these reactions if they occur.
Datroway may cause fetal harm during pregnancy. Females of reproductive potential should use effective contraception during treatment and for seven months after the final dose. Breastfeeding should be avoided during treatment and for at least one month after the last dose because of the potential for serious adverse reactions in a nursing infant.
Patients should inform their healthcare providers about all prescription medications, over-the-counter products, vitamins, and supplements before beginning treatment to ensure appropriate monitoring and reduce the risk of treatment-related complications.
Access to Multiple Medications
Support Beyond Datroway
Those who need cancer treatment assistance typically need more than one medication to help treat their condition and medication side effects.
Because of this, many patients are curious about multiple medication assistance programs.
Prescription Hope can help. With our list of hundreds of brand-name medications, we can help patients who qualify get access to their meds…no matter how many they qualify for on our list.
No matter how many meds we help with, our service fee remains a simple $70.00 per month, per medication.
Why Choose Prescription Hope for Datroway Assistance
Patient-Focused Medication Support
For 20 years, Prescription Hope has helped patients across the nation get access to their needed brand-name medications. Our team of trained advocates knows how to navigate the complex patient assistance program landscape and offer compassionate care throughout the process.
Medication Management
Our team not only advocates on your behalf throughout the patient assistance program application process, but they also take care of all the required administrative tasks after approval. They handle things like refill scheduling, document updates, yearly renewals, program monitoring, and more.
Clear Monthly Pricing
Our service fee is a simple and clear $70.00 per month, per medication. No hidden charges, no add-on fees, and no medication costs.
Nationwide Medication Access Support
We’ve grown our network to include manufacturers and healthcare providers across the nation, offering in-depth service that helps patients get access to their meds…no matter their location.
If you’re looking to apply for the Datroway patient assistance program, then be sure to enroll with Prescription Hope today.
